Insmed
INSM
#562
Rank
โ‚ฌ35.31 B
Marketcap
165,58ย โ‚ฌ
Share price
2.37%
Change (1 day)
140.16%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚ฌ0.98 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ0.44 Billion. In 2024 the company made an earning of -โ‚ฌ0.71 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.98 Billion38.24%
2024 -โ‚ฌ0.71 Billion23.71%
2023 -โ‚ฌ0.58 Billion45.77%
2022 -โ‚ฌ0.4 Billion15.83%
2021 -โ‚ฌ0.34 Billion50.19%
2020 -โ‚ฌ0.23 Billion16.4%
2019 -โ‚ฌ0.2 Billion-23.9%
2018 -โ‚ฌ0.26 Billion59.35%
2017 -โ‚ฌ0.16 Billion8.52%
2016 -โ‚ฌ0.15 Billion47.25%
2015 -โ‚ฌ99.91 Million34.53%
2014 -โ‚ฌ74.27 Million58.83%
2013 -โ‚ฌ46.76 Million35.14%
2012 -โ‚ฌ34.61 Million-31.92%
2011 -โ‚ฌ50.83 Million854.92%
2010 -โ‚ฌ5.33 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ12.66 Million-27.31%
2007 -โ‚ฌ17.42 Million-62.41%
2006 -โ‚ฌ46.33 Million98.19%
2005 -โ‚ฌ23.38 Million0.03%
2004 -โ‚ฌ23.37 Million159.07%
2003 -โ‚ฌ9.02 Million-69.31%
2002 -โ‚ฌ29.39 Million
2000 -โ‚ฌ26.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.98 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ8.42 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ3.75 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ19.81 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ3.80 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA